Viewing StudyNCT04888468



Ignite Creation Date: 2024-05-06 @ 4:07 PM
Last Modification Date: 2024-10-26 @ 2:04 PM
Study NCT ID: NCT04888468
Status: COMPLETED
Last Update Posted: 2022-03-18
First Post: 2021-05-12

Brief Title: Phase I Study of pCAR-19B in the Treatment of CD19-positive RelapsedRefractory B-ALL in Children and Adolescents
Sponsor: Chongqing Precision Biotech Co Ltd
Organization: Chongqing Precision Biotech Co Ltd

Conditions & Keywords Data

Conditions:
Name
Refractory Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Relapsed Pediatric ALL
Keywords:
Name View
B-ALL View
CAR-T View
CD19 View